Found: 28
Select item for more details and to access through your institution.
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
New Insights into Monoclonal B-Cell Lymphocytosis.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/258917
- By:
- Publication type:
- Article
Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, <sup>Tyr</sup>p-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/251479
- By:
- Publication type:
- Article
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/159632
- By:
- Publication type:
- Article
Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.
- Published in:
- Scientific Reports, 2016, p. 21252, doi. 10.1038/srep21252
- By:
- Publication type:
- Article
Extranodal Marginal-Zone Lymphomas: An Entity with Significant Heterogeneity at Different Anatomic Sites.
- Published in:
- Acta Haematologica, 2019, v. 142, n. 2, p. 59, doi. 10.1159/000496380
- By:
- Publication type:
- Article
Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 240, doi. 10.1111/j.1365-2141.2007.06561.x
- By:
- Publication type:
- Article
Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 597, doi. 10.1002/onco.13789
- By:
- Publication type:
- Article
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1149, doi. 10.1634/theoncologist.2015-0180
- By:
- Publication type:
- Article
Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 190, doi. 10.1634/theoncologist.2012-0251
- By:
- Publication type:
- Article
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 239, doi. 10.1634/theoncologist.2011-0275
- By:
- Publication type:
- Article
Early-Stage Gastric MALT Lymphoma: Is It a Truly Localized Disease?
- Published in:
- Oncologist, 2009, v. 14, n. 2, p. 148, doi. 10.1634/theoncologist.2008-0178
- By:
- Publication type:
- Article
Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 6, p. 531, doi. 10.1111/j.1600-0609.2007.00961.x
- By:
- Publication type:
- Article
Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 4, p. 300, doi. 10.1111/j.1600-0609.2006.00720.x
- By:
- Publication type:
- Article
Clinical Aspects of Malt Lymphomas.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 3, p. 262, doi. 10.1007/s11899-014-0218-1
- By:
- Publication type:
- Article
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 99, doi. 10.3816/CLML.2011.n.019
- By:
- Publication type:
- Article
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
- By:
- Publication type:
- Article
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
- By:
- Publication type:
- Article
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 1, p. 10, doi. 10.1002/hon.2012
- By:
- Publication type:
- Article
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1302, doi. 10.21873/invivo.12831
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6945, doi. 10.3390/jcm12216945
- By:
- Publication type:
- Article
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3462, doi. 10.3390/jcm10163462
- By:
- Publication type:
- Article
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2279, doi. 10.1007/s00277-021-04421-2
- By:
- Publication type:
- Article